The CAMINISA brand, founded in 2014 (United States), from 61 sister brands and 17477 competing brands. CAMINISA is owned by Biogen Idec, listed on the stock exchange of New York CAMINISA belongs to the Drug Manufacturers business sector.

CAMINISA is a brand of Biogen Idec (BIIB) Share price

Share price and profitability of the share Biogen Idec (CAMINISA)

Buy Biogen Idec share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 201.99

Portfolio valuation
Biogen Idec (CAMINISA) over 5 years* USD 177.58

Stock market history Biogen Idec (CAMINISA)

Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more